Albendazole therapy in patients with solitary cerebral cysticercus granuloma. Is it effective?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 3, 2008, Pages 238-239

  Rajshekhar, Vedantam ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT;

CYSTICERCUS; DRUG EFFICACY; DRUG WITHDRAWAL; EDITORIAL; GRANULOMA; HUMAN; NEUROCYSTICERCOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; SEIZURE; SOLITARY CYSTICERCUS GRANULOMA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ALBENDAZOLE; ANTHELMINTICS; BRAIN DISEASES; GRANULOMA; HUMANS; NEUROCYSTICERCOSIS; RESEARCH DESIGN;

EID: 39749130377     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.136515     Document Type: Editorial

References (5)

1. Thussu A, Chattopadhyay A, Sawhney IMS, et al. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008;79:272-5.
2. Rajshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients presenting with seizures. Neurology 2001;57:2315-17.
3. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004;62:2236- 40.
4. Rajshekhar V. Albendazole therapy for persistent solitary Cysticercus granulomas in patients with seizures. Neurology 1993;43:1238-40.
5. Del Brutto OH, Roos KL, Coffey CS, et al. Metaanalysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.